Migraine disorders / fatigue

Serotonin containing formulation for oral administration and method of use

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION This invention relates, in general, to the oral administration of serotonin. The serotonin containing compositions are useful in controlling pain such as in migraine headaches, premenstrual syndrome(PMS), eating disorders, and depression in animals. This invention further

Enzyme formulation for reducing histamine intolerance

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the

Enzyme formulation for reducing histamine intolerance

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the

Pharmaceutically active morpholinol

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

This invention relates to an optically pure morpholinol, salts and solvates thereof, pharmaceutical formulations containing them and processes for their preparation and use. BACKGROUND OF THE INVENTION Bupropion hydrochloride, (.+-.)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)-amino]-1-propanone

2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Neuronal nicotinic acetylcholine receptors (nAChRs) serve a wide range of physiological functions and have been implicated in a number of pathological processes and pharmacological effects of nicotinic drugs. Many of the important in vivo effects of nicotine in the

2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Neuronal nicotinic acetylcholine receptors (nAChRs) serve a wide range of physiological functions and have been implicated in a number of pathological processes and pharmacological effects of nicotinic drugs. Many of the important in vivo effects of nicotine in the

2-halo-5-alkynyl-pyridyl nicotinic ligands

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated cation channels in the central nervous system (CNS) and the peripheral nervous system (PNS). The nAChRs serve a wide range of physiological functions, and have been implicated in a number of pathological

2-halo-5-alkynyl-pyridyl nicotinic ligands

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated cation channels in the central nervous system (CNS) and the peripheral nervous system (PNS). The nAChRs serve a wide range of physiological functions, and have been implicated in a number of pathological

Phenyl-substituted nicotinic ligands, and methods of use thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Neuronal nicotinic acetylcholine receptors (nAChRs) serve a wide range of physiological functions and have been implicated in a number of pathological processes and pharmacological effects of nicotinic drugs. Many of the important in vivo effects of nicotine in the

Phenyl-substituted nicotinic ligands, and methods of use thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Neuronal nicotinic acetylcholine receptors (nAChRs) serve a wide range of physiological functions and have been implicated in a number of pathological processes and pharmacological effects of nicotinic drugs. Many of the important in vivo effects of nicotine in the

Ligands for nicotinic acetylcholine receptors, and methods of making and using them

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION The endogenous cholinergic neurotransmitter, acetylcholine, exert its biological effect via two types of cholinergic receptors; the muscarinic ACh receptors and the nicotinic ACh receptors. As it is well established that muscarinic ACh receptors dominate quantitatively

Cytokine antagonists for neurological and neuropsychiatric disorders

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION The present invention relates to novel methods of use of specific cytokine antagonists for the treatment of neuropsychiatric and neurological disorders in humans. More particularly, these cytokine antagonists are used in a new treatment of neuropsychiatric and neurologic

Cytokine antagonists for neurological and neuropsychiatric disorders

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION The present invention relates to novel methods of use of specific cytokine antagonists for the treatment of neuropsychiatric and neurological disorders in humans. More particularly, these cytokine antagonists are used in a new treatment of neuropsychiatric and neurologic

migraine disorders/fatigue

Serotonin containing formulation for oral administration and method of use

Enzyme formulation for reducing histamine intolerance

Enzyme formulation for reducing histamine intolerance

Pharmaceutically active morpholinol

2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof

2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof

2-halo-5-alkynyl-pyridyl nicotinic ligands

2-halo-5-alkynyl-pyridyl nicotinic ligands

Phenyl-substituted nicotinic ligands, and methods of use thereof

Phenyl-substituted nicotinic ligands, and methods of use thereof

Ligands for nicotinic acetylcholine receptors, and methods of making and using them

Cytokine antagonists for neurological and neuropsychiatric disorders

Cytokine antagonists for neurological and neuropsychiatric disorders

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne